Annual Cash & Cash Equivalents
$865.00 M
-$63.00 M-6.79%
31 December 2023
Summary:
Boston Scientific annual cash & cash equivalents is currently $865.00 million, with the most recent change of -$63.00 million (-6.79%) on 31 December 2023. During the last 3 years, it has fallen by -$1.06 billion (-55.06%). BSX annual cash & cash equivalents is now -55.06% below its all-time high of $1.93 billion, reached on 31 December 2021.BSX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.50 B
-$411.00 M-14.11%
30 September 2024
Summary:
Boston Scientific quarterly cash and cash equivalents is currently $2.50 billion, with the most recent change of -$411.00 million (-14.11%) on 30 September 2024. Over the past year, it has increased by +$1.64 billion (+189.25%). BSX quarterly cash and cash equivalents is now -14.11% below its all-time high of $2.91 billion, reached on 30 June 2024.BSX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BSX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +189.3% |
| 3 y3 years | -55.1% | +30.0% |
| 5 y5 years | +298.6% | +1053.0% |
BSX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.1% | at low | -14.1% | +806.5% |
| 5 y | 5 years | -55.1% | +298.6% | -14.1% | +1053.0% |
| alltime | all time | -55.1% | >+9999.0% | -14.1% | >+9999.0% |
Boston Scientific Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.50 B(-14.1%) |
| June 2024 | - | $2.91 B(+25.1%) |
| Mar 2024 | - | $2.33 B(+169.2%) |
| Dec 2023 | $865.00 M(-6.8%) | $865.00 M(-9.1%) |
| Sept 2023 | - | $952.00 M(+123.5%) |
| June 2023 | - | $426.00 M(-25.3%) |
| Mar 2023 | - | $570.00 M(-38.6%) |
| Dec 2022 | $928.00 M(-51.8%) | $928.00 M(+174.6%) |
| Sept 2022 | - | $338.00 M(+22.5%) |
| June 2022 | - | $276.00 M(-15.1%) |
| Mar 2022 | - | $325.00 M(-83.1%) |
| Dec 2021 | $1.93 B(+11.0%) | $1.93 B(-1.1%) |
| Sept 2021 | - | $1.95 B(-27.2%) |
| June 2021 | - | $2.67 B(+32.7%) |
| Mar 2021 | - | $2.02 B(+16.3%) |
| Dec 2020 | $1.73 B(+699.1%) | $1.73 B(-14.2%) |
| Sept 2020 | - | $2.02 B(+17.3%) |
| June 2020 | - | $1.72 B(+365.9%) |
| Mar 2020 | - | $370.00 M(+70.5%) |
| Dec 2019 | $217.00 M(+48.6%) | $217.00 M(-21.7%) |
| Sept 2019 | - | $277.00 M(+125.2%) |
| June 2019 | - | $123.00 M(-11.5%) |
| Mar 2019 | - | $139.00 M(-4.8%) |
| Dec 2018 | $146.00 M(-22.3%) | $146.00 M(-13.1%) |
| Sept 2018 | - | $168.00 M(-19.2%) |
| June 2018 | - | $208.00 M(-27.5%) |
| Mar 2018 | - | $287.00 M(+52.7%) |
| Dec 2017 | $188.00 M(-4.1%) | $188.00 M(-10.5%) |
| Sept 2017 | - | $210.00 M(+7.7%) |
| June 2017 | - | $195.00 M(+25.0%) |
| Mar 2017 | - | $156.00 M(-20.4%) |
| Dec 2016 | $196.00 M(-38.6%) | $196.00 M(-17.3%) |
| Sept 2016 | - | $237.00 M(-45.9%) |
| June 2016 | - | $438.00 M(+29.6%) |
| Mar 2016 | - | $338.00 M(+6.0%) |
| Dec 2015 | $319.00 M(-45.7%) | $319.00 M(-8.9%) |
| Sept 2015 | - | $350.00 M(-61.2%) |
| June 2015 | - | $903.00 M(+273.1%) |
| Mar 2015 | - | $242.00 M(-58.8%) |
| Dec 2014 | $587.00 M(+170.5%) | $587.00 M(+138.6%) |
| Sept 2014 | - | $246.00 M(-31.1%) |
| June 2014 | - | $357.00 M(+86.9%) |
| Mar 2014 | - | $191.00 M(-12.0%) |
| Dec 2013 | $217.00 M(+4.8%) | $217.00 M(-62.0%) |
| Sept 2013 | - | $571.00 M(+7.7%) |
| June 2013 | - | $530.00 M(+97.8%) |
| Mar 2013 | - | $268.00 M(+29.5%) |
| Dec 2012 | $207.00 M(-22.5%) | $207.00 M(-41.2%) |
| Sept 2012 | - | $352.00 M(-5.1%) |
| June 2012 | - | $371.00 M(+30.6%) |
| Mar 2012 | - | $284.00 M(+6.4%) |
| Dec 2011 | $267.00 M(+25.4%) | $267.00 M(-3.3%) |
| Sept 2011 | - | $276.00 M(+79.2%) |
| June 2011 | - | $154.00 M(-74.1%) |
| Mar 2011 | - | $595.00 M(+179.3%) |
| Dec 2010 | $213.00 M(-75.3%) | $213.00 M(-73.7%) |
| June 2010 | - | $811.00 M(+56.3%) |
| Mar 2010 | - | $519.00 M(-39.9%) |
| Dec 2009 | $864.00 M(-47.3%) | $864.00 M(-37.4%) |
| Sept 2009 | - | $1.38 B(+15.7%) |
| June 2009 | - | $1.19 B(+33.1%) |
| Mar 2009 | - | $897.00 M(-45.3%) |
| Dec 2008 | $1.64 B | $1.64 B(-5.4%) |
| Sept 2008 | - | $1.73 B(+7.3%) |
| June 2008 | - | $1.62 B(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.74 B(+19.8%) |
| Dec 2007 | $1.45 B(-12.9%) | $1.45 B(+17.4%) |
| Sept 2007 | - | $1.24 B(-18.3%) |
| June 2007 | - | $1.51 B(+13.0%) |
| Mar 2007 | - | $1.34 B(-19.7%) |
| Dec 2006 | $1.67 B(+142.1%) | $1.67 B(+8.2%) |
| Sept 2006 | - | $1.54 B(+33.2%) |
| June 2006 | - | $1.16 B(+6.8%) |
| Mar 2006 | - | $1.08 B(+57.2%) |
| Dec 2005 | $689.00 M(-46.8%) | $689.00 M(-7.5%) |
| Sept 2005 | - | $745.00 M(+6.7%) |
| June 2005 | - | $698.00 M(-15.6%) |
| Mar 2005 | - | $827.00 M(-36.2%) |
| Dec 2004 | $1.30 B(+93.1%) | $1.30 B(-16.0%) |
| Sept 2004 | - | $1.54 B(+22.1%) |
| June 2004 | - | $1.26 B(+105.4%) |
| Mar 2004 | - | $615.00 M(-8.3%) |
| Dec 2003 | $671.00 M(+142.2%) | $671.00 M(+25.0%) |
| Sept 2003 | - | $537.00 M(+31.0%) |
| June 2003 | - | $410.00 M(+39.5%) |
| Mar 2003 | - | $294.00 M(+6.1%) |
| Dec 2002 | $277.00 M(+53.9%) | $277.00 M(+6.9%) |
| Sept 2002 | - | $259.00 M(+79.9%) |
| June 2002 | - | $144.00 M(-28.4%) |
| Mar 2002 | - | $201.00 M(+11.7%) |
| Dec 2001 | $180.00 M(+233.3%) | $180.00 M(+81.8%) |
| Sept 2001 | - | $99.00 M(+80.0%) |
| June 2001 | - | $55.00 M(-34.5%) |
| Mar 2001 | - | $84.00 M(+55.6%) |
| Dec 2000 | $54.00 M(-15.6%) | $54.00 M(+20.0%) |
| Sept 2000 | - | $45.00 M(+2.3%) |
| June 2000 | - | $44.00 M(-21.4%) |
| Mar 2000 | - | $56.00 M(-12.5%) |
| Dec 1999 | $64.00 M(-8.6%) | $64.00 M(-11.1%) |
| Sept 1999 | - | $72.00 M(+4.3%) |
| June 1999 | - | $69.00 M(-37.3%) |
| Mar 1999 | - | $110.00 M(+57.1%) |
| Dec 1998 | $70.00 M(+20.7%) | $70.00 M(-64.1%) |
| Sept 1998 | - | $194.90 M(+31.2%) |
| June 1998 | - | $148.60 M(+4.2%) |
| Mar 1998 | - | $142.60 M(+145.9%) |
| Dec 1997 | $58.00 M(-19.7%) | $58.00 M(+6.8%) |
| Sept 1997 | - | $54.30 M(+0.4%) |
| June 1997 | - | $54.10 M(-24.4%) |
| Mar 1997 | - | $71.60 M(-0.8%) |
| Dec 1996 | $72.20 M(-37.3%) | $72.20 M(+21.5%) |
| Sept 1996 | - | $59.40 M(+12.7%) |
| June 1996 | - | $52.70 M(-49.4%) |
| Mar 1996 | - | $104.10 M(-9.6%) |
| Dec 1995 | $115.10 M(+27.9%) | $115.10 M(-25.7%) |
| Sept 1995 | - | $155.00 M(-14.1%) |
| June 1995 | - | $180.50 M(-5.6%) |
| Mar 1995 | - | $191.20 M(+112.4%) |
| Dec 1994 | $90.00 M(+48.0%) | $90.00 M(-5.6%) |
| Sept 1994 | - | $95.30 M(+38.3%) |
| June 1994 | - | $68.90 M(-2.4%) |
| Mar 1994 | - | $70.60 M(+16.1%) |
| Dec 1993 | $60.80 M(-36.3%) | $60.80 M(+24.8%) |
| Sept 1993 | - | $48.70 M(-5.6%) |
| June 1993 | - | $51.60 M(-50.2%) |
| Mar 1993 | - | $103.60 M(+8.6%) |
| Dec 1992 | $95.40 M(+1516.9%) | $95.40 M(-26.5%) |
| Sept 1992 | - | $129.80 M(+10.2%) |
| June 1992 | - | $117.80 M(+1254.0%) |
| Mar 1992 | - | $8.70 M(+47.5%) |
| Dec 1991 | $5.90 M | $5.90 M |
FAQ
- What is Boston Scientific annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Boston Scientific?
- What is Boston Scientific quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Boston Scientific?
- What is Boston Scientific quarterly cash and cash equivalents year-on-year change?
What is Boston Scientific annual cash & cash equivalents?
The current annual cash & cash equivalents of BSX is $865.00 M
What is the all time high annual cash & cash equivalents for Boston Scientific?
Boston Scientific all-time high annual cash & cash equivalents is $1.93 B
What is Boston Scientific quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BSX is $2.50 B
What is the all time high quarterly cash and cash equivalents for Boston Scientific?
Boston Scientific all-time high quarterly cash and cash equivalents is $2.91 B
What is Boston Scientific quarterly cash and cash equivalents year-on-year change?
Over the past year, BSX quarterly cash and cash equivalents has changed by +$1.64 B (+189.25%)